Literature DB >> 24512929

Circadian disruption and fatal ovarian cancer.

Brian D Carter1, W Ryan Diver2, Janet S Hildebrand2, Alpa V Patel2, Susan M Gapstur2.   

Abstract

BACKGROUND: The International Agency for Research on Cancer determination that shift work is a "probable" human carcinogen was based primarily on studies of breast cancer but it was also noted that additional aspects of circadian disruption and other cancer sites deserved further research.
PURPOSE: To examine possible associations of three measures of circadian disruption: nontypical work schedules, nightly sleep duration, and monthly frequency of insomnia with risk of fatal ovarian cancer in a sample of American women.
METHODS: Several measures of circadian disruption and other information were assessed in 1982 from 161,004 employed women in the American Cancer Society's Cancer Prevention Study-II, a cohort that has been followed for mortality through 2010. In 2013, Cox proportional hazards regression was used to model the relative risks (RRs) and 95% CIs of death from ovarian cancer for categories of each indicator of circadian disruption.
RESULTS: Over 28 years of follow-up, 1289 deaths from ovarian cancer occurred in the at-risk cohort. Compared to fixed daytime work, a rotating schedule was associated with an elevated risk of fatal ovarian cancer (RR=1.27, 95% CI=1.03, 1.56). No significant associations were observed for sleep duration (p trend=0.24) or insomnia (p trend=0.44).
CONCLUSIONS: In this large prospective study, there was a higher risk of fatal ovarian cancer in women who reported a rotating work schedule. These findings and the high prevalence of rotating shift schedules underscore the need for further research examining the role of work schedule and risk of ovarian cancer.
Copyright © 2014 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24512929     DOI: 10.1016/j.amepre.2013.10.032

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  16 in total

Review 1.  Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment.

Authors:  Gabriele Sulli; Michael Tun Yin Lam; Satchidananda Panda
Journal:  Trends Cancer       Date:  2019-08-03

Review 2.  Measuring Light at Night and Melatonin Levels in Shift Workers: A Review of the Literature.

Authors:  Claudia M Hunter; Mariana G Figueiro
Journal:  Biol Res Nurs       Date:  2017-07       Impact factor: 2.522

3.  Urinary melatonin and risk of ovarian cancer.

Authors:  Elizabeth M Poole; Eva Schernhammer; Leigha Mills; Susan E Hankinson; Shelley S Tworoger
Journal:  Cancer Causes Control       Date:  2015-07-30       Impact factor: 2.506

4.  Opportunities for cancer prevention during midlife: highlights from a meeting of experts.

Authors:  Dawn M Holman; Melissa Grossman; S Jane Henley; Lucy A Peipins; Laura Tison; Mary C White
Journal:  Am J Prev Med       Date:  2014-03       Impact factor: 5.043

5.  Forging an integrated agenda for primary cancer prevention during midlife.

Authors:  Sarah Gehlert
Journal:  Am J Prev Med       Date:  2014-03       Impact factor: 5.043

6.  Sleep duration and cancer risk in women.

Authors:  Susan Hurley; Debbie Goldberg; Leslie Bernstein; Peggy Reynolds
Journal:  Cancer Causes Control       Date:  2015-04-30       Impact factor: 2.532

Review 7.  Circadian rhythms and the gut microbiota: from the metabolic syndrome to cancer.

Authors:  Faraz Bishehsari; Robin M Voigt; Ali Keshavarzian
Journal:  Nat Rev Endocrinol       Date:  2020-10-26       Impact factor: 47.564

Review 8.  Protecting the melatonin rhythm through circadian healthy light exposure.

Authors:  Maria Angeles Bonmati-Carrion; Raquel Arguelles-Prieto; Maria Jose Martinez-Madrid; Russel Reiter; Ruediger Hardeland; Maria Angeles Rol; Juan Antonio Madrid
Journal:  Int J Mol Sci       Date:  2014-12-17       Impact factor: 5.923

Review 9.  Prevention of fatigue and insomnia in shift workers-a review of non-pharmacological measures.

Authors:  Kneginja Richter; Jens Acker; Sophia Adam; Guenter Niklewski
Journal:  EPMA J       Date:  2016-08-02       Impact factor: 6.543

10.  Carcinogenic effects of circadian disruption: an epigenetic viewpoint.

Authors:  Abbas Salavaty
Journal:  Chin J Cancer       Date:  2015-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.